Caribou Biosciences (CRBU) Share-based Compensation (2020 - 2025)
Historic Share-based Compensation for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to $2.9 million.
- Caribou Biosciences' Share-based Compensation fell 2796.76% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.9 million, marking a year-over-year decrease of 1527.74%. This contributed to the annual value of $16.7 million for FY2024, which is 2149.82% up from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' Share-based Compensation is $2.9 million, which was down 2796.76% from $3.1 million recorded in Q2 2025.
- Caribou Biosciences' Share-based Compensation's 5-year high stood at $4.7 million during Q2 2024, with a 5-year trough of $343000.0 in Q1 2021.
- Over the past 5 years, Caribou Biosciences' median Share-based Compensation value was $3.1 million (recorded in 2025), while the average stood at $2.9 million.
- In the last 5 years, Caribou Biosciences' Share-based Compensation soared by 78163.27% in 2022 and then tumbled by 3395.95% in 2025.
- Over the past 5 years, Caribou Biosciences' Share-based Compensation (Quarter) stood at $1.6 million in 2021, then soared by 96.51% to $3.1 million in 2022, then increased by 14.67% to $3.6 million in 2023, then grew by 9.98% to $3.9 million in 2024, then dropped by 25.06% to $2.9 million in 2025.
- Its Share-based Compensation was $2.9 million in Q3 2025, compared to $3.1 million in Q2 2025 and $3.9 million in Q1 2025.